| Mrs Kimberly A Cali, CRNA | |
|
1 Cooper Plz Dept Of, Camden, NJ 08103-1461 | |
| (856) 342-2425 | |
| (856) 968-8326 |
| Full Name | Mrs Kimberly A Cali |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 1 Cooper Plz Dept Of, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184978066 | NPI | - | NPPES |
| AANA | Other | 90280 |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inspira Medical Center Vineland | Vineland, NJ | Hospital |
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Jersey Healthcare Specialists Pc | 2668385253 | 554 |
| Rancocas Anesthesiology Pa | 2769380237 | 88 |
News Archive
Scientists at the University of Liverpool have developed a new method to help researchers identify genes that can help protect the body during the ageing process.
Everyday Health, Inc., a leading digital health and wellness company, today announced a strategic partnership with Wildflower Health. Through this partnership, Everyday Health expands its suite of offerings to help health plans and employers reach and engage pregnant women earlier in their pregnancies to improve health outcomes and reduce medical costs.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).
› Verified 5 days ago
| Entity Name | New Jersey Healthcare Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174585780 PECOS PAC ID: 2668385253 Enrollment ID: O20031110000555 |
News Archive
Scientists at the University of Liverpool have developed a new method to help researchers identify genes that can help protect the body during the ageing process.
Everyday Health, Inc., a leading digital health and wellness company, today announced a strategic partnership with Wildflower Health. Through this partnership, Everyday Health expands its suite of offerings to help health plans and employers reach and engage pregnant women earlier in their pregnancies to improve health outcomes and reduce medical costs.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).
› Verified 5 days ago
| Entity Name | Cooper Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447207147 PECOS PAC ID: 1254236672 Enrollment ID: O20031126000651 |
News Archive
Scientists at the University of Liverpool have developed a new method to help researchers identify genes that can help protect the body during the ageing process.
Everyday Health, Inc., a leading digital health and wellness company, today announced a strategic partnership with Wildflower Health. Through this partnership, Everyday Health expands its suite of offerings to help health plans and employers reach and engage pregnant women earlier in their pregnancies to improve health outcomes and reduce medical costs.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).
› Verified 5 days ago
| Entity Name | Rancocas Anesthesiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427076553 PECOS PAC ID: 2769380237 Enrollment ID: O20031222000327 |
News Archive
Scientists at the University of Liverpool have developed a new method to help researchers identify genes that can help protect the body during the ageing process.
Everyday Health, Inc., a leading digital health and wellness company, today announced a strategic partnership with Wildflower Health. Through this partnership, Everyday Health expands its suite of offerings to help health plans and employers reach and engage pregnant women earlier in their pregnancies to improve health outcomes and reduce medical costs.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kimberly A Cali, CRNA 1 Federal St Ste 200, Camden, NJ 08103-1088 Ph: (848) 288-6935 | Mrs Kimberly A Cali, CRNA 1 Cooper Plz Dept Of, Camden, NJ 08103-1461 Ph: (856) 342-2425 |
News Archive
Scientists at the University of Liverpool have developed a new method to help researchers identify genes that can help protect the body during the ageing process.
Everyday Health, Inc., a leading digital health and wellness company, today announced a strategic partnership with Wildflower Health. Through this partnership, Everyday Health expands its suite of offerings to help health plans and employers reach and engage pregnant women earlier in their pregnancies to improve health outcomes and reduce medical costs.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).
› Verified 5 days ago
Winter E. Skelly, CRNA, APN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz Dept Of, Camden, NJ 08103 Phone: 856-342-2425 | |
Balaishe Boakai Ballo, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3500 | |
Michael Phillip Hoess, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 | |
Amy Tsao, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Cooper Plz Dept Of, Camden, NJ 08103 Phone: 856-382-6500 | |
Maria Dinnah Eclavia-dy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Cooper Anesthesia Associates, Camden, NJ 08103 Phone: 856-342-2425 | |
Meredith Christina Defusco, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 | |
Amber Klein, APN-A CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3500 |